Detalhe da pesquisa
1.
The diagnostic process of cervical cancer; areas of good practice, and windows of opportunity.
Gynecol Oncol
; 138(2): 405-10, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037902
2.
Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study.
Int J Gynecol Cancer
; 24(2): 303-11, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407577
3.
Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
Int J Gynecol Cancer
; 22(1): 107-14, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21857347
4.
IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
J Immunol
; 181(4): 2446-54, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18684935
5.
SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
Gynecol Oncol
; 112(1): 119-25, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19007978
6.
Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
Int J Cancer
; 123(8): 1848-53, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18661524
7.
In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
Clin Immunol
; 129(1): 145-54, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18707922
8.
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Tumour Biol
; 29(1): 9-17, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18497544
9.
Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.
Anticancer Res
; 28(5A): 2721-5, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19035301
10.
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
Cancer Lett
; 257(1): 47-55, 2007 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-17692456
11.
Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
Cancer Res
; 65(17): 7880-7, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16140958
12.
Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
J Histochem Cytochem
; 51(6): 761-71, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12754287
13.
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study.
J Cancer Res Clin Oncol
; 128(9): 484-92, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12242512
14.
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2.
J Biomed Biotechnol
; 2003(3): 194-201, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12975534
15.
Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
Ann Clin Biochem
; 40(Pt 6): 663-73, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14629806
16.
Natural and Induced Humoral Responses to MUC1.
Cancers (Basel)
; 3(3): 3073-103, 2011 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24212946
17.
Vaccine-induced antibody responses in patients with carcinoma.
Expert Rev Vaccines
; 9(6): 579-94, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20518714
18.
Differential indirect activation of human invariant natural killer T cells by Toll-like receptor agonists.
Immunotherapy
; 1(4): 557-70, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20635987
19.
Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer.
Cancer Res
; 68(11): 4442-6, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18519707
20.
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Cancer Lett
; 272(1): 70-6, 2008 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18684557